BPC-157 vs Melanotan II
Overview
BPC-157 is primarily a healing & recovery peptide, while Melanotan II is used for cosmetic & skin.
This page compares BPC-157 and Melanotan II across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| BPC-157 | Melanotan II | |
|---|---|---|
| Category | Healing & Recovery | Cosmetic & Skin |
| Regulatory status (US) | Not approved — Cat. 2 removed (Apr 2026) | Not approved — Cat. 2 removed (Apr 2026) |
| Typical dosage | 250-500 mcg | — |
| Frequency | daily | — |
| Reported benefits | Accelerated wound healing, tendon and ligament repair, gut health improvement, reduced inflammation, neuroprotective effects | Skin tanning without UV exposure, increased libido, potential appetite suppression |
| Reported side effects | Generally well-tolerated. Rare: injection site reactions, mild fatigue | Nausea, facial flushing, darkening of moles, potential cardiovascular effects |
Key differences
Primary use. BPC-157 is categorised under Healing & Recovery, while Melanotan II falls under Cosmetic & Skin. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. BPC-157: not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it. Melanotan II: not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
Dosing. BPC-157 is typically dosed at 250-500 mcg (daily). Typical dosing for Melanotan II is not catalogued.
Can you stack them?
Some protocols combine peptides, but stacking BPC-157 and Melanotan II has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between BPC-157 and Melanotan II?
- BPC-157 is primarily a healing & recovery peptide, while Melanotan II is used for cosmetic & skin. BPC-157 is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it, whereas Melanotan II is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
- What is BPC-157 used for?
- Healing & recovery, gut health.
- What is Melanotan II used for?
- Tanning, libido.
- Can you take BPC-157 and Melanotan II together?
- Some users combine peptides within a single protocol, but stacking BPC-157 and Melanotan II has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is BPC-157 or Melanotan II FDA-approved?
- BPC-157 is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it. Melanotan II is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
Read the full articles
- BPC-157 — full monograph: mechanism, research, dosing & references
- Melanotan II — full monograph: mechanism, research, dosing & references